People doubted this stock, but they’re wrong

Business


Amgen: “I am not going to recommend this stock here.”

Sarepta Therapeutics: “I think they’re brilliant. I think they’ve got the right combination. I think that a lot of people doubted them. I think those people are wrong.”

Wingstop: “Wingstop is one terrific stock.”

Regenxbio: “I will have to do some homework on that.”

Visa: “Visa’s fantastic.”

WP Carey: “It’s O. K. That’s all I’m going to say.”

WATCH: Cramer’s lighting round

Disclosure: Cramer’s charitable trust owns shares of Amgen.

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Jim Cramer TwitterFacebookInstagram

Questions, comments, suggestions for the “Mad Money” website? madcap@cnbc.com





Source link

Articles You May Like

CBS, Viacom set August 8 as informal deadline for merger talks
FANG stocks have lost their characteristic mojo, but investors are sticking with them
UnitedHealth earnings Q2 2019
Avoiding costly Medicare mistakes when retiring past age 65
Watch SpaceX Starship fireball in video after rocket engine test

Leave a Reply

Your email address will not be published. Required fields are marked *